Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: April 28, 2011
Last updated: April 3, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)